Multiple and Mixed Valvular Heart Disease¶
Chapter 279 | Part 6: Disorders of the Cardiovascular System
KEY CLINICAL POINTS¶
- Mixed valvular disease involves coexisting stenosis/regurgitation at multiple valves (e.g., mitral and aortic), often due to rheumatic fever, carcinoid heart disease, or congenital anomalies.
- Functional tricuspid regurgitation (TR) is common in severe mitral valve disease, masking underlying right heart failure symptoms.
- Diagnosis requires integrated clinical and noninvasive assessment (echocardiography, CMR, CT) to identify dominant lesions and guide management.
- Treatment depends on dominant lesion, with surgical AVR or TAVI for aortic stenosis, and mitral valve repair/repair for secondary MR.
- Prognosis is influenced by dominant lesion severity, with significant paravalvular regurgitation linked to poor outcomes after TAVI.
1. DEFINITION & OVERVIEW¶
Multiple and mixed valvular heart disease refers to coexisting stenosis or regurgitation at two or more heart valves. Common etiologies include rheumatic fever, carcinoid heart disease, congenital anomalies, and secondary valve dysfunction from conditions like aortic stenosis (AS) or mitral regurgitation (MR). Functional TR often accompanies severe mitral valve disease, complicating clinical assessment.
1.1 Common Etiologies¶
Rheumatic fever, carcinoid heart disease, congenital anomalies (e.g., bicuspid aortic valve), and secondary valve dysfunction from AS/MR. Ergotamines and fenfluramine-phentermine combinations may cause mixed aortic/mitral lesions.
1.2 Clinical Challenges¶
Symptoms may develop earlier due to combined hemodynamic effects. Functional TR and secondary MR can mask severity of coexisting lesions. Diagnostic accuracy requires integration of clinical findings and imaging.
2. EPIDEMIOLOGY¶
Rheumatic fever is a major cause in developing countries; carcinoid heart disease affects 10-20% of carcinoid tumor patients. Mixed valve disease is more common in patients with long-standing valvular disease, especially those with AS or MR. Secondary MR occurs in 10-20% of severe AS patients.
2.1 Risk Factors¶
Rheumatic fever, carcinoid tumor, congenital valve abnormalities, mediastinal radiation, and connective tissue disorders (e.g., Marfan syndrome). Obesity and diabetes may contribute to cardiac amyloidosis.
2.2 Demographics¶
Rheumatic valvular disease is more prevalent in developing countries. Carcinoid heart disease typically affects middle-aged adults. Marfan syndrome-associated valve disease occurs in 50-70% of patients.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Rheumatic fever causes inflammation and scarring of multiple valves. Carcinoid heart disease leads to fibrosis of tricuspid and pulmonic valves. Secondary MR develops from LV remodeling in severe AS. Mixed lesions may alter hemodynamics by affecting transvalvular flow and CO.
Hemodynamic Effects of Mixed Valvular Disease¶
| Lesion Combination | Key Hemodynamic Effects | Clinical Implications |
|---|---|---|
| AS + AR | LV dilation, elevated PVR | Increased risk of heart failure |
| MS + MR | Reduced CO, elevated LA pressure | Risk of AF and pulmonary hypertension |
| TR + TS | Right ventricular overload, RA hypertension | Masked by left-sided disease |
3.1 Rheumatic Valvular Disease¶
Inflammation and scarring of mitral, aortic, and tricuspid valves. Common in developing countries with poor rheumatic fever control.
3.2 Secondary MR¶
Caused by LV remodeling in severe AS. Mitral leaflets remain normal but become tethered by elevated LV pressures. Functional MR may persist after AVR.
3.3 Hemodynamic Interactions¶
Mixed lesions complicate assessment of valve severity. For example, AR may elevate LV-aortic Doppler gradients, masking true valve area. Gorlin formula is inaccurate in mixed valve disease.
4. CLINICAL FEATURES¶
Symptoms include exertional dyspnea, fatigue, palpitations (AF), and signs of right heart failure (edema, ascites). Functional TR may present with large c-v waves in RA pressure pulse. Mixed lesions may cause atypical presentations due to overlapping hemodynamic effects.
4.1 Left-Sided Disease¶
Dyspnea, fatigue, angina (due to LV ischemia), and signs of pulmonary hypertension (Kerley B lines, pulmonary venous engorgement).
4.2 Right-Sided Disease¶
Abdominal distension, peripheral edema, and signs of RA hypertension (enlarged azygos vein).
4.3 Mixed Disease¶
Atypical presentations due to combined effects. Early symptoms may include both left and right heart failure manifestations.
5. DIFFERENTIAL DIAGNOSIS¶
Distinguish from single-valve disease, patent ductus arteriosus (PDA), ruptured sinus of Valsalva aneurysm, and other valvular disorders. Functional TR vs. organic TR, and secondary MR vs. primary MR require careful echocardiographic evaluation.
5.1 Functional vs. Organic Lesions¶
Functional TR is due to RV dilation; organic TR involves valve pathology. Secondary MR is due to LV remodeling vs. primary MR from valve prolapse.
5.2 Mixed Lesions¶
Differentiate from PDA or ruptured sinus of Valsalva aneurysm with continuous murmurs. Assess for concurrent systemic conditions (e.g., carcinoid, amyloidosis).
6. INVESTIGATIONS & DIAGNOSIS¶
Echocardiography (TTE/TEE) is the primary tool for valve morphology, function, and hemodynamic assessment. CMR and CT provide complementary anatomical data. Invasive hemodynamics may be required for complex cases.
Diagnostic Imaging Modalities¶
| Modality | Key Applications | Advantages |
|---|---|---|
| TTE | Valve function, chamber size, Doppler flow | Widely available, noninvasive |
| TEE | Mitral valve anatomy, IE detection | Higher resolution for complex lesions |
| CMR | LV function, myocardial mass, valve morphology | Quantitative assessment of hemodynamics |
6.1 Noninvasive Imaging¶
TTE: Assess valve morphology, chamber size, and Doppler flow. TEE: Evaluate mitral valve anatomy and IE. CMR: Quantify LV function and myocardial mass.
6.2 Invasive Studies¶
Right/left heart catheterization for PA pressures, PVR, and valve-specific hemodynamics. Required when clinical findings conflict with noninvasive data.
6.3 Diagnostic Criteria¶
Valve morphology, regurgitant jet size, transvalvular gradients, and chamber dimensions. Use of Doppler-derived parameters (e.g., E wave velocity) to assess severity.
7. MANAGEMENT & TREATMENT¶
Treatment depends on dominant lesion. Surgical AVR/TAVI for aortic stenosis; mitral valve repair/repair for secondary MR. Management of AF and heart failure is critical. Concomitant valve interventions may improve outcomes.
Treatment Algorithms for Mixed Valvular Disease¶
| Dominant Lesion | Primary Intervention | Adjunctive Therapies |
|---|---|---|
| Aortic Stenosis | AVR/TAVI | Anticoagulation for AF, diuretics |
| Mitral Regurgitation | Mitral Valve Repair | Management of LV remodeling |
| Functional TR | Management of Left-Sided Disease | Control of pulmonary hypertension |
7.1 Surgical Interventions¶
AVR for AS, mitral valve repair for secondary MR. Concomitant repair of multiple valves in high-risk patients. TAVI for inoperable patients with severe AS and MR.
7.2 Medical Management¶
Diuretics for congestion, anticoagulation for AF, and vasodilators for pulmonary hypertension. Avoid systemic hypotension in left-sided regurgitant lesions.
7.3 Complications¶
Paravalvular regurgitation after TAVI, persistent secondary MR, and poor outcomes with untreated mixed lesions. Early intervention improves prognosis.
8. PROGNOSIS & COMPLICATIONS¶
Prognosis depends on dominant lesion severity. Mixed lesions with significant paravalvular regurgitation have poor short-term outcomes. Complications include heart failure, AF, pulmonary hypertension, and sudden cardiac death.
8.1 Survival Outcomes¶
Patients with severe AS and MR have higher mortality. TAVI outcomes worsen with significant paravalvular regurgitation. Early intervention improves survival.
8.2 Long-Term Risks¶
Progressive LV dysfunction, recurrent AF, and pulmonary hypertension. Secondary MR may persist after AVR, leading to poor functional outcomes.
9. SPECIAL CONSIDERATIONS¶
Pregnancy requires careful management of anticoagulation and valve function. Pediatric patients may present with congenital mixed lesions. Elderly patients with comorbidities face higher surgical risks. Radiation-induced valvular disease requires multidisciplinary care.
9.1 Pregnancy¶
Avoid anticoagulants with fetal risk. Monitor for maternal heart failure and fetal growth restriction. Consider early delivery in severe cases.
9.2 Pediatric Considerations¶
Congenital mixed lesions (e.g., bicuspid aortic valve) may require early intervention. Monitor for aortic dissection risk in Marfan syndrome.
9.3 Elderly Patients¶
Higher surgical risk due to comorbidities. TAVI may be preferred over surgical AVR for high-risk patients.
10. KEY POINTS & CLINICAL PEARLS¶
Identify dominant lesion through integrated clinical and imaging assessment. Functional TR and secondary MR often mask severity of coexisting lesions. TAVI outcomes are worsened by paravalvular regurgitation. Early intervention improves prognosis in mixed valvular disease. Use Doppler-derived parameters to assess valve severity in complex cases.